Dr. Timothy Haystead is a UK-educated Doctor of Biochemistry, University Professor, entrepreneur, and world-renowned scientific researcher.

Dr. Haystead graduated with a Bachelor of Science (BSc) in Biochemistry from Cardiff University (United Kingdom) and a PhD in Biochemistry from the University of Dundee (United Kingdom).

He and his wife (a medical doctor) immigrated to the US to “seek adventure” in a new country. Dr. Haystead’s career in academia commenced in Seattle, traveled through the University of Virginia, and drew to a stop at the prestigious Duke University. During his adventures in academia, he trained under and worked with four Nobel Laureate scientists.

Dr. Haystead’s entrepreneurial efforts developed a drug discovery platform to take guesswork or “luck” out of the process of identifying disease diagnostic and treatment tools. He founded two companies to develop and commercialize his drug discovery platform. He sold his first company, named Serenex, to Pfizer. He is working to build a new company that he started out of a “garage” in close proximity to Duke University.

After meeting and working with the famous Duke University Lyme disease researcher, Dr. Neil Spector, he was inspired to use his drug discovery platform to pioneer diagnostic and treatment tools for Lyme disease. Dr. Haystead’s Lyme research has earned the recognition and support of grants from the National Institute of Health (NIH), Centers for Disease Control (CDC), US Department of Defense, Cohen Foundation, and the Bay Area Lyme Foundation. The grant-funded research is being conducted in collaboration with researchers from Duke, Tulane, and NC State University.

If you would like to learn more about how Dr. Haystead is working to pioneer tools to detect and eliminate Lyme bacteria by destroying its DNA, then tune in now!